Keele UniversityFaculty of Health
School of Pharmacy
Explore this Section
- Undergraduate
- Postgraduate
- Medicines Management
- Research Agenda
- Publications
- MTRAC
- MTRAC Verdict Sheets & ESCAs
- MTRAC Commissioning Support Summary Sheets & ESCAs
- Contacts
- Constitution [PDF]
- Latest News
- Register with MTRAC
- Keele Medicines Management Services
- National Pathology Benchmarking Service
- Prescribing Decision Support
- ESCA Toolkit
- NPC Plus
- Virtual Patient
- Staff & Research Interests
- Faculty of Health >
- School of Pharmacy >
- Medicines Management >
- MTRAC >
- MTRAC Commissioning Support Summary Sheets & ESCAs
MTRAC Commissioning Support Summary Sheets & ESCAs
Note: Verdict Sheets issued prior to August 2010 are listed under MTRAC Verdict Sheets & ESCAs.
| Drug Name (Indication) | Trade Names | Summary Date | Links |
|
Buprenorphine Transdermal Patch |
Transtec®, Butrans® | Jan 2012 | [Summary] |
| Cannabinoids | Sativex® | Feb 2011 | [Summary] |
| Dabigatran | Pradaxa® | March 2012 | [Summary] |
| Dronedarone | Multaq® | April 2011 | [ESCA] |
| Exenatide (once weekly) | Bydureon® | October 2011 | [Summary] |
|
Fentanyl Transdermal Patch |
March 2012 | [Summary] | |
| Insulin glargine | Lantus® | Dec 2010 | [Summary] |
| Leuprorelin (prostate cancer) | Prostap® | Dec 2010 | |
| Roflumilast | Daxas® | May 2011 | [Summary] |
| Ticagrelor | Brilique® | May 2011 | [Summary] |
This symbol indicates that the drug has been "archived" and will not be actively updated except for a compelling reason or request.
